샘플 요청 목록

 카트 문의
시장보고서
상품코드
2056824

영양유전체학 시장

Nutrigenomics
발행일: | 리서치사: 구분자 Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 168 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 8,948,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 26,844,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 영양유전체학 시장은 2032년까지 14억 달러에 이를 전망

2025년에 4억 7,900만 달러로 추정되는 세계의 영양유전체학 시장은 2025년부터 2032년까지 분석 기간 중 CAGR 17.1%로 성장하여 2032년까지 14억 달러에 이를 것으로 예상되고 있습니다. 본 보고서로 분석 대상이 되고 있는 부문 중 하나인 '영양유전체학 시약 및 키트'는 17.9%의 CAGR을 기록해, 분석 기간 종료까지 9억 8,240만 달러에 이를 것으로 예상되고 있습니다. '영양유전체학 서비스' 부문의 성장률은 분석 기간 중 CAGR 15.5%이 된다고 추정되고 있습니다.

미국 시장은 1억 4,020만 달러로 추계되는 한편, 중국은 CAGR 16.3%를 나타낼 것으로 예측됩니다

2025년 미국 영양유전체학 시장 규모는 1억 4,020만 달러로 추계되고 있습니다. 세계 제 2위 경제 규모를 자랑하는 중국은 2025년부터 2032년까지 분석 기간 중 CAGR 16.3%로 성장을 지속하여, 2032년까지 시장 규모가 2억 4,870만 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역 시장으로서는 일본과 캐나다를 들 수 있어 분석 기간 중에 각각 CAGR 16.0% 및 14.9%를 나타낼 것으로 예측됩니다. 유럽내에서는 독일이 약 12.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계의 영양유전체학 시장-주요 동향과 촉진요인 개요

영양유전체학은 개인 맞춤형 영양을 어떻게 변화시키고 있는가?

유전자와 영양소 및 식재료와의 상호작용을 연구하는 영양유전체학은 개인의 유전적 구성이 식사의 필요와 반응에 어떻게 영향을 미치는지에 대한 인사이트를 제공함으로써 개인 맞춤형 영양의 개념을 재정의하고 있습니다. 이 연구 분야는 비만, 당뇨병, 심혈관 질환 등 다양한 질병에 대한 유전적 소인을 파악하여 건강 상태를 개선할 수 있는 맞춤형 영양 계획을 수립할 수 있도록 돕습니다. 영양유전체학은 헬스케어 분야에서 특히 유용하게 활용될 수 있습니다. 유전정보에 기반한 식습관 중재를 통해 만성질환의 위험을 관리하고 완화할 수 있습니다. 건강과 웰빙에 대한 소비자의 인식이 높아지면서 영양 유전체학은 개인 맞춤형 영양의 필수적인 요소로 자리 잡고 있으며, 보다 정확한 식단 추천을 통해 더 나은 건강 관리를 실현하고 있습니다.

영양유전체학 시장의 주요 부문은?

주요 제품으로는 유전자 기반 영양 중재를 위한 검사 키트, 서비스, 보충제 등이 있습니다. 용도 측면에서 영양유전체학은 식단 평가, 체중 관리, 스포츠 영양학, 헬스케어 등에 활용되고 있으며, 개인 맞춤형 식단을 통한 질병 예방에 대한 관심이 높아짐에 따라 헬스케어 분야가 가장 큰 비중을 차지하고 있습니다. 영양유전체학의 주요 최종 사용자로는 연구기관, 의료 제공업체, 유전자 검사 회사, 개인 맞춤형 식단 계획을 원하는 소비자 등이 있습니다. 일반 소비자 대상(DTC) 유전자 검사 서비스의 이용 가능성이 높아짐에 따라 영양유전체학의 적용 범위가 넓어지고, 더 많은 사람들이 쉽게 이용할 수 있게 되었습니다.

영양유전체학은 건강 및 웰니스 분야에서 어떻게 통합되고 있을까?

의료 서비스 제공업체는 특히 당뇨병, 비만, 고혈압과 같은 질병을 관리하기 위해 환자에게 개인화된 식단을 추천하기 위해 영양유전체학을 활용하고 있습니다. 유전자 검사 회사는 영양소 대사, 식품 과민증, 비타민 결핍과 관련된 유전적 소인에 대한 지식을 소비자에게 제공하는 영양유전체학 검사를 제공합니다. 스포츠 영양 업계도 유전 정보를 기반으로 선수들의 식단을 최적화하고, 운동 능력과 회복력을 향상시키기 위해 영양유전체학을 활용하고 있습니다. 또한, 웰니스 프로그램과 피트니스 센터에서는 전인적 건강 관리의 일환으로 영양유전체학을 도입하여 개인의 유전자 프로파일에 맞는 맞춤형 식단 계획을 제공합니다. 디지털 건강 플랫폼과 모바일 앱에 영양 유전체학이 통합되면서 소비자들이 개인 맞춤형 영양 지침에 더 쉽게 접근할 수 있게 되었습니다.

영양유전체학 시장의 성장을 이끄는 요인은 무엇인가?

영양유전체학 시장의 성장은 유전, 식습관, 건강 결과의 연관성에 대한 소비자의 인식이 높아지는 등 여러 요인에 의해 주도되고 있습니다. 건강 인식 증가와 예방적 건강 관리에 대한 관심으로 인해 개인 맞춤형 영양 솔루션에 대한 수요가 증가하면서 영양유전체학의 확산이 가속화되고 있습니다. 유전자 검사 기술의 발전으로 영양유전체학 분석이 더욱 정확하고, 저렴하고, 쉽게 이용할 수 있게 되면서 시장의 성장이 더욱 가속화되고 있습니다. 체중관리, 스포츠 영양학, 만성질환 예방에 대한 뉴트리노믹스의 활용 확대도 그 적용 범위를 넓혀가고 있습니다. 또한, DTC(소비자 직접 판매) 유전자 검사 서비스의 확산과 디지털 건강 플랫폼에 유전적 지식을 통합하는 것은 헬스케어 및 웰니스 분야 전반에 걸쳐 영양유전체학의 광범위한 보급에 기여하고 있습니다.

부문:

제품(시약 및 키트, 서비스), 용도(비만, 암 연구, 심혈관질환, 기타 용도)

주요 기업

  • BASF SE
  • Cell-Logic
  • Danone S.A
  • Fagron Genomics S.L.U.
  • Genova Diagnostics
  • GX Sciences, LLC.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Unilever
  • Xcode Life

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

JHS

Global Nutrigenomics Market to Reach US$1.4 Billion by 2032

The global market for Nutrigenomics estimated at US$479.0 Million in the year 2025, is expected to reach US$1.4 Billion by 2032, growing at a CAGR of 17.1% over the analysis period 2025-2032. Nutrigenomics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$982.4 Million by the end of the analysis period. Growth in the Nutrigenomics Services segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$140.2 Million While China is Forecast to Grow at 16.3% CAGR

The Nutrigenomics market in the U.S. is estimated at US$140.2 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$248.7 Million by the year 2032 trailing a CAGR of 16.3% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 14.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Nutrigenomics Market - Key Trends and Drivers Summarized

How Is Nutrigenomics Reshaping Personalized Nutrition?

Nutrigenomics, the study of how genes interact with nutrients and dietary components, is redefining personalized nutrition by offering insights into how an individual’s genetic makeup influences their dietary needs and responses. This field of study helps identify genetic predispositions to various conditions like obesity, diabetes, and cardiovascular diseases, enabling the development of tailored nutritional plans that enhance health outcomes. Nutrigenomics is particularly beneficial in preventive healthcare, where dietary interventions based on genetic information can help manage or mitigate the risk of chronic diseases. With growing consumer awareness of health and wellness, nutrigenomics is becoming an essential component of personalized nutrition, offering more precise dietary recommendations for better health management.

What Are the Key Segments in the Nutrigenomics Market?

Key products include testing kits, services, and supplements designed for genetic-based nutrition interventions. In terms of application, nutrigenomics is used in dietary assessment, weight management, sports nutrition, and preventive healthcare, with preventive healthcare representing the largest segment due to the growing focus on disease prevention through personalized diets. The major end-users of nutrigenomics include research institutions, healthcare providers, genetic testing companies, and consumers seeking personalized diet plans. The increasing availability of direct-to-consumer (DTC) genetic testing services has expanded the reach of nutrigenomics, making it more accessible to a broader audience.

How Is Nutrigenomics Being Integrated Across Health and Wellness Sectors?

Healthcare providers are adopting nutrigenomics to deliver personalized dietary recommendations to patients, particularly for managing conditions like diabetes, obesity, and hypertension. Genetic testing companies offer nutrigenomic tests that provide consumers with insights into their genetic predispositions related to nutrient metabolism, food sensitivities, and vitamin deficiencies. The sports nutrition industry also utilizes nutrigenomics to optimize athletes’ diets based on genetic information, improving performance and recovery. Additionally, wellness programs and fitness centers are incorporating nutrigenomics as part of holistic health management, offering tailored dietary plans that align with individual genetic profiles. The integration of nutrigenomics into digital health platforms and mobile apps has further enhanced consumer access to personalized nutrition guidance.

What Factors Are Driving the Growth in the Nutrigenomics Market?

The growth in the Nutrigenomics market is driven by several factors, including increasing consumer awareness of the link between genetics, diet, and health outcomes. The rising demand for personalized nutrition solutions, driven by growing health consciousness and interest in preventive healthcare, has fueled the adoption of nutrigenomics. Advances in genetic testing technologies have made nutrigenomic analysis more accurate, affordable, and accessible, further boosting market growth. The increasing use of nutrigenomics in weight management, sports nutrition, and chronic disease prevention has also expanded its application. Additionally, the proliferation of DTC genetic testing services and the integration of genetic insights into digital health platforms have contributed to the broader adoption of nutrigenomics across healthcare and wellness sectors.

SCOPE OF STUDY:

The report analyzes the Nutrigenomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Kits, Services); Application (Obesity, Cancer Research, Cardiovascular Diseases, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

SELECT PLAYERS -

  • BASF SE
  • Cell-Logic
  • Danone S.A
  • Fagron Genomics S.L.U.
  • Genova Diagnostics
  • GX Sciences, LLC.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Unilever
  • Xcode Life

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 10,115 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Nutrigenomics - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Nutrition and Health Supplements Spurs Growth in Nutrigenomics Market
    • Technological Advancements in Genomic Testing and Bioinformatics Strengthen Business Case for Adoption
    • Growing Focus on Tailored Diet Plans and Wellness Programs Expands Addressable Market
    • Expansion of Nutrigenomics in Clinical Laboratories, Nutrition Clinics, and Wellness Centers Fuels Market Growth
    • Increasing Adoption of Nutrigenomics in Weight Management, Metabolic Disorders, and Diabetes Care Expands Market Opportunities
    • Technological Innovations in DNA-Based Dietary Analysis and Nutrient Mapping Propel Market Expansion
    • Rising Focus on Preventive Healthcare and Reducing Chronic Disease Risks Drives Demand for Nutrigenomics
    • Growing Use of Nutrigenomics in Functional Foods, Sports Nutrition, and Dietary Supplements Expands Market Potential
    • Technological Advancements in AI-Powered Nutritional Recommendations and Microbiome Integration Propel Market Growth
    • Increasing Focus on Integrating Nutrigenomics with Telemedicine and Digital Health Platforms Drives Adoption
    • Rising Demand for Nutrigenomics in Fitness, Anti-Aging, and Mental Health Applications Strengthens Global Market
    • Expansion of Nutrigenomics in Personalized Meal Kits, Health Coaching, and Virtual Nutrition Counseling Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 6: World 13-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 9: World 13-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 10: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 11: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 12: World 13-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 13: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 14: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 15: World 13-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 17: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 18: World 13-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 21: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 22: World Nutrigenomics Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 24: USA Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 25: USA 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 27: USA Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 28: USA 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 30: Canada Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 31: Canada 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 33: Canada Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 34: Canada 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • JAPAN
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 36: Japan Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 37: Japan 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Japan Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 40: Japan 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • CHINA
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 42: China Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 43: China 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 44: China Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 45: China Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 46: China 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • EUROPE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 48: Europe Historic Review for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 49: Europe 13-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 52: Europe 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 55: Europe 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • FRANCE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 57: France Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 58: France 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 59: France Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 60: France Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 61: France 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • GERMANY
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Germany Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 64: Germany 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Germany Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 67: Germany 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Italy Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 70: Italy 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Italy Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 73: Italy 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 75: UK Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 76: UK 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 78: UK Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 79: UK 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 82: Rest of Europe 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 85: Rest of Europe 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 88: Asia-Pacific 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 91: Asia-Pacific 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Rest of World Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 94: Rest of World 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Rest of World Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 97: Rest of World 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기